May 18, 2021
Google AI tool can help patients identify skin conditions
Optellum has been mentioned in a BBC article about a new Google AI tool.
Dermatology Assist has not yet been given clearance by the Food and Drug Administration (FDA) for use in the US, but a similar machine-learning model built by British firm Optellum was recently approved by the FDA for use as an assistant in the diagnosis of lung cancer.
Zoe Kleinman, Technology reporter, BBC news
Recent posts
August 24, 2026 / News & Press, Partnerships
SimonMed Launches World’s First Seamlessly Integrated AI Lung Nodule Risk Assessment WorkflowSimonMed is creating the first fully automated AI-powered lung cancer risk assessment workflow deployed at enterprise scale, combining multiple FDA-cleared AI technologies into a...
Read more
August 13, 2026 / News & Press, Partnerships
Coreline Soft and Optellum announce intent to collaborate to advance AI...Proposed collaboration would make Coreline Soft's FDA-cleared lung nodule detection capability available through Optellum's LungOS® platform
Read more
June 15, 2026 / News & Press, Partnerships
Optellum Awarded NIHR Funding for Multi-Site NHS Pilot Study for Accelerated...Optellum announced it has been awarded funding for a competitive programme, Invention for Innovation (i4i), focused on transformative and disruptive innovations to reduce waiting...
Read more
Optellum is trusted by industry & academic leaders
Certification
Redefining early intervention of lung disease
starting with one of the deadliest, lung cancer
Contact us